DRKS00005954已完成不适用
The role of the endocannabinoidsystem and the immune system in chronic pain - alterations in comparison to healthy volunteers and influence of pain treatment
Interdisziplinäre Schmerzambulanz und Tageskinik, LMU München, Klinikum Großhadern0 个研究点目标入组 98 人开始时间: 2014年3月12日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 98
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 70 Years（—）
- 性别
- All
入选标准
- •Patients with chronic nociceptive and/or neuropathic pain without medication or stable medication for at least 14 days
排除标准
- •Pregnancy, psychological/mental disorder, addiction, glucocorticoid treatment
研究者
相似试验
撤回
不适用
The role of the endocannabinoid system in Attention-Deficit/Hyperactivity Disorder and symptoms: a pharmacological fMRI studyADHDAttention-Deficit/Hyperactivity Disorder10037176NL-OMON35106niversitair Medisch Centrum Utrecht24
已完成
不适用
The effects of endocannabinoid system deficits induced by early-life stress on fear memory extinctioEarly-life stressed peopleNL-OMON21224Radboudumc, Nijmegen48
已完成
不适用
Investigation of the role of the cannabinoid system in mediating alcohol cue-induced Nucleus accumbens response in individuals with alcohol Use disorder using functional magnetic resonance imagingAlcohol Use Disorder (DSM-5)DRKS00029993Zentralinstitut für Seelische Gesundheit Klinik für Abhängiges Verhalten und Suchtmedizin28
已完成
不适用
The Role of the Endocannabinoid System in Psychiatric Disorders and Symptoms: a Pharmacological fMRI studysmoking10037176addictionNL-OMON33616niversitair Medisch Centrum Utrecht48
进行中（未招募）
不适用
The Role of the Endocannabinoid System in Psychiatric Disorders and Symptoms: a Pharmacological fMRI study - THC-phMRI in patientsTHis research project will be performed with patients with a psychiatric disorder in order to determine whether the endocannabinoid system is altered in psychiatric diseases. Psychistric disorders that are investigated are schizophrenia, depression, ADHD, OCD and addiction. Patients will be compared with healthy controls.MedDRA version: 9.1Level: SOCClassification code 10037175Term: Psychiatric disordersMedDRA version: 9.1Level: LLTClassification code 10051623Term: CannabinoidsEUCTR2007-004247-30-NLniversity Medical Center Utrecht